![](/img/cover-not-exists.png)
DECREASED ORGAN FAILURE IN PATIENTS WITH SEVERE SIRS AND SEPTIC SHOCK TREATED WITH THE PLATELET-ACTIVATING FACTOR ANTAGONIST TCV-309: A PROSPECTIVE, MULTICENTER, DOUBLE-BLIND, RANDOMIZED PHASE II TRIAL
Poeze, Martijn, Froon, Albert H. M., Ramsay, Graham, Buurman, Wim A., Greve, Jan Willem M.Volume:
14
Journal:
Shock
DOI:
10.1097/00024382-200014040-00001
Date:
October, 2000
File:
PDF, 6.18 MB
2000